Advanced Triple-Negative Breast Carcinoma
3 clinical trials · Condition
◉ Watch Advanced Triple-Negative Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484) | National Cancer Institute (NCI) | 2021-11-22 |
| Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer (NCT03941730) | Mayo Clinic | 2019-08-28 |
Track Advanced Triple-Negative Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.